MetaCap

Valneva Statistics

NASDAQ: VALNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

5.16-0.205 (-3.82%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Valneva by the numbers

Valneva has a market capitalization of $490.9 million based on 95.13M shares outstanding. With trailing EPS of $-2.10, Valneva is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.6% below its 50-day average and 20.9% below its 200-day average.

Average daily trading volume is 23.10K shares, or about $119,196 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

VALN valuation vs. peer median

VALN compared with the median of 8 peer companies
MetricVALNPeer medianDifference
Market cap$490.86M$474.93M+3%
Avg. volume23.10K974.35K-98%

Peer median across 8 companies: DNA, SANA, RGNX, ETRA, FENC, IRLA, PROK, DBVT.

Valuation

Price and trading

Previous close
5.37
Open
5.30
Day range
5.12 – 5.30
52-week range
4.75 – 12.18
52-week change
-40.14%
Beta
—
Volume
17.55K

Dividends and events

Annual dividend
None
Next earnings date
Nov 24, 2026

Additional statistics

Market Cap
490.86M
Forward Pe
4.34
Eps
-2.10
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
12.18
Week52 Low
4.75
Avg Volume
23,100.00
Shares Outstanding
95.13M
Ma50
5.84
Ma200
6.52
Earnings Date
Nov 24, 2026
Pct From52w High
-57.64%
Pct From52w Low
8.63%

Related